*attL* and *attR*

:   attachment sequence left and right

CI

:   circular intermediate

CTX

:   cholera toxin phage

GI

:   genomic island

NGS

:   next generation sequencing

ORF

:   open reading frame

SNP

:   single nucleotide polymorphism

VSP

:   *Vibrio* seventh pandemic island

*Vibrio cholerae*, the causative agent of the severe watery diarrheal disease cholera, has been spreading globally as a result of its high adaptation and ability to cause explosive outbreaks. Cholera still remains a significant public health concern in many areas of the world because of its high morbidity and mortality. Seven cholera pandemics have been described in human history since 1817 [1](#mim12570-bib-0001){ref-type="ref"}. The classical biotype is considered the cause of the first six cholera pandemics, whereas the seventh and current, which emerged from the Indonesian island of Sulawesi in 1961, is mainly caused by strains of the El Tor biotype. This current seventh pandemic is the longest pandemic that has ever been recorded, lasting more than half a century [2](#mim12570-bib-0002){ref-type="ref"}. It is the most disastrous pandemic in terms of geographical area and number of people infected [3](#mim12570-bib-0003){ref-type="ref"}. Analysis of representative historical and recent *V. cholerae* isolates indicated eight distinct phyletic lineages L1‐L8, the L1 being classical isolates, the L2 representing El Tor isolates of the seventh pandemic, which was further subdivided into three independent overlapping waves based on SNP in the genome and the type of CTX they harbored [4](#mim12570-bib-0004){ref-type="ref"}. Wave 1, wave 2 and wave 3 strains originated from a single ancestor in the Bay of Bengal [4](#mim12570-bib-0004){ref-type="ref"}, [5](#mim12570-bib-0005){ref-type="ref"} and subsequently have spread to Asia, Africa and Latin America. The current seventh pandemic is believed to have emerged from a non‐pathogenic strain after acquisition of important virulent factors: VSP‐I, and −II, and El Tor type of CTX [6](#mim12570-bib-0006){ref-type="ref"}. VSP‐I and −II were reported for the first time and described to be unique to the seventh pandemic El Tor strains by Dziejman *et al*. [7](#mim12570-bib-0007){ref-type="ref"}. VSP‐II was originally identified as a 7.5‐kb region which was subsequently described by O\'Shea *et al*. to be part of a 26.9‐kb region spanning from VC0490 to VC0516 [7](#mim12570-bib-0007){ref-type="ref"}, [8](#mim12570-bib-0008){ref-type="ref"}. VSP‐I and −II were described to be received by the seventh pandemic strains by lateral gene transfer event and hypothesized to increase the fitness advantage of the isolates [7](#mim12570-bib-0007){ref-type="ref"}, [9](#mim12570-bib-0009){ref-type="ref"}, [10](#mim12570-bib-0010){ref-type="ref"}. The insertion site of VSP‐II is at the tRNA‐methionine locus, VC0516.1. The island is integrated between two attachment sequences, *attL* (14 bp) and *attR* (16 bp) [11](#mim12570-bib-0011){ref-type="ref"}, [12](#mim12570-bib-0012){ref-type="ref"}. Significant diversity of VSP‐II was observed in previous studies with the main focus on the genomic variation of the island [8](#mim12570-bib-0008){ref-type="ref"}, [12](#mim12570-bib-0012){ref-type="ref"}, [13](#mim12570-bib-0013){ref-type="ref"}. Here we analyzed a wide variety of strains, presenting different biotypes and serogroups collected from numerous geographical locations and covering a wide time period. The present study aims to investigate the broader genetic variation of VSP‐II, identify variation of VSP‐II attachment site sequences, and identify VSP‐II relevant GI. We categorized *V. cholerae* strains with SNP and invariable sites analyses, and pathogenicity and virulence profiles were estimated by determining species‐specific gene (*ompW*), serogroup‐specific genes (*wbe* O1, *wbf* O139), biotype‐specific genes (*tcpA, rstR, ctxB*), virulence genes (*ctxB, ctxA, tcpA*). The analysis showed a novel VSP‐II variant, six new categories of VSP‐II attachment sequences, and four new GI sharing conserved gene clusters with VSP‐II. Significantly, the 13‐bp attachment sequence was found associated with the absence of VSP‐II in the seventh pandemic lineage.

MATERIALS AND METHODS {#mim12570-sec-0003}
=====================

*V. cholerae* strains and DNA extraction {#mim12570-sec-0004}
----------------------------------------

Out of 188 *V. cholerae* strains analyzed, 178 strains were of our laboratory collection, isolated from Asian and African countries. Colonies grown on nutrient agar were inoculated in Heart Infusion Broth (Nissui, Tokyo, Japan) and cultured at 37°C overnight with shaking. Genomic DNA extraction was carried out by QIAGEN DNeasy Blood & Tissue Kits (QIAGEN, Valencia, CA, USA) according to the manufacturer\'s instructions. Information on 10 other strains was downloaded from GenBank and used for the analyses. All *V. cholerae* strains each with an accession number are listed in Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}. C‐genome SNP and invariable sites analyses were carried out for categorizing all *V. cholerae* strains into five groups as follows: non‐O1/non‐O139, pre‐seventh pandemic, seventh pandemic wave 1, seventh pandemic wave 2, and seventh pandemic wave 3 (Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}).

Whole genome sequencing data {#mim12570-sec-0005}
----------------------------

Purified genomic DNA extracts were subjected to whole genome random sequencing analysis with NGS by HiSeq 2000 and HiSeq 2500 instruments (Illumina, San Diego, CA, USA). The library was prepared by Nextera XT kit (Illumina) and TruSeq Nano DNA Sample preparation kit (Illumina) according to the manufacturer\'s instructions. Paired‐end reads were checked using FastQC version 0.11.5, sequencing reads were sampled at 72‐fold genome size to reduce computational resources. Quality‐based trimming was done using Sickle version 1.33. De novo assemblies were carried out using different parameters in CLC Genomics Workbench 8.5.1, and Velvet version 1.2.09 [14](#mim12570-bib-0014){ref-type="ref"}, [15](#mim12570-bib-0015){ref-type="ref"}. The resulting contigs with short length \<200 bp were filtered out with home customized‐script. The assemblies were further improved by Metassembler version 1.5 [16](#mim12570-bib-0016){ref-type="ref"}, and MeGAMerge‐1.0 [17](#mim12570-bib-0017){ref-type="ref"}. Mapping of the reads to the references using CLC Genomics Workbench is a second approach in addition to the de novo assemblies. Strains O395, N16961, and MJ‐1236 were used as references for the mapping.

Genome annotation and comparative genomic analysis {#mim12570-sec-0006}
--------------------------------------------------

Complete and draft genomes were annotated by Prokka version 1.12 [18](#mim12570-bib-0018){ref-type="ref"} and ORFfinder (<https://www.ncbi.nlm.nih.gov/orffinder>), if necessary. Comparison files that contain blast‐hits with sequence identity were generated using BLAST+ 2.2.31 [19](#mim12570-bib-0019){ref-type="ref"}, and visualized with genoPlotR package in R [20](#mim12570-bib-0020){ref-type="ref"}.

Identification of VSP‐II and novel GI {#mim12570-sec-0007}
-------------------------------------

Identification of the VSP‐II region was based on mapping of the reads to the reference strain N16961. The novel VSP‐II was identified as a GI sharing a similar integrase gene (annotated as integrase and having ≥80% similarity over ≥70% sequence length) inserted at the site between VC0489 and VC0517 and was not described previously. In this study, the VSP‐II relevant GI was defined as any GI that shares at least one similar gene with VSP‐II, but not a similar integrase gene.

Pathogenicity and virulence profiling {#mim12570-sec-0008}
-------------------------------------

DNA sequence identification using a BLAST search against a prepared local BLAST database in the CLC Genomics Workbench was carried out to determine the presence of the species‐specific gene (*ompW)*, O‐antigen biosynthesis serogroup specific genes (*wbe* O1 and *wbf* O139), biotype‐specific genes (*tcpA*, *rstR* and *ctxB)*, and virulence gene *ctxA* [21](#mim12570-bib-0021){ref-type="ref"}, [22](#mim12570-bib-0022){ref-type="ref"}. Type of *ctxB* and *rstR* genes was determined by nucleotide variation described elsewhere [23](#mim12570-bib-0023){ref-type="ref"}.

RESULTS {#mim12570-sec-0009}
=======

Categorization of *V. cholerae* strains {#mim12570-sec-0010}
---------------------------------------

All 188 *V. cholerae* strains were confirmed to carry *ompW*. Alignment of 1763 core genes with a length of 1,693,138 base pairs identified out of a predicted 8535 genes containing 105,941 core genome SNP was used for categorization of *V. cholerae* strains. Analyses indicated that 154 strains were *V. cholerae* O1 biotype El Tor, 23 were *V. cholerae* O139, and 11 strains were non‐O1/non‐O139 (Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}).

Distribution of VSP‐II among *V. cholerae* strains {#mim12570-sec-0011}
--------------------------------------------------

Any type of VSP‐II identified in the study was inserted at the site between genes VC0489 and VC0517 and harbored an identical integrase gene. Among the 188 *V. cholerae* analyzed, 81% (153/188) of strains carried any type of VSP‐II; of these, typical VSP‐II, and a short variant with VC0495‐VC0498 deletion was found in 36% (55/153), and 63% (96/153), respectively. In the present study, four ORF, VC0502b, VC0511b, VC0511c, and VC0512b in the typical VSP‐II were newly annotated as ZnuA precursor, transposition protein of transposon Tn7, a transposase, and uncharacterized protein, respectively (Supplementary Table [S2](#mim12570-sup-0002){ref-type="supplementary-material"} and Fig. [1](#mim12570-fig-0001){ref-type="fig"}). A novel VSP‐II was identified to be 18.8 kb in size, encompassing 21 ORF, and was found in two *V. cholerae* non‐O1/non‐O139 strains (Fig. [1](#mim12570-fig-0001){ref-type="fig"}). The novel VSP‐II harbored two gene clusters, VC0495--VC0498 and VC0504--VC0510, with 94--97% DNA identities to the corresponding clusters of the typical VSP‐II (Fig. [1](#mim12570-fig-0001){ref-type="fig"}). Pairwise comparison of deduced amino acids indicated that a transcriptional regulator and a ribonuclease HI were found in the VC0495--VC0498 cluster, and a transcriptional factor MdcH and a DNA repair protein RadC were encoded in the VC0504--VC0510 cluster (Supplementary Table [S2](#mim12570-sup-0002){ref-type="supplementary-material"}).

![**Comparative analysis of VSP‐II in 188 *Vibrio cholerae* strains** (a) Genetic organization of the typical seventh pandemic VSP‐II of strain N16961 was used as reference. (b,c) Genetic organizations of VSP‐II with VC0495--VC0498 deletion and the novel VSP‐II variant are shown, respectively. (d) Schematic of chromosomal flanking region of VSP‐II negative strains is indicated. Number of strain carriers is presented (*n*). Genes are shown by arrows, with the direction indicating the coding strand. Chromosomal flanking genes are in black. Conserved gene clusters are highlighted in grey. Integrase gene is in green. Attachment left and right sites (*attL* and *attR*) are shown by tiny vertical black bars. Similar regions based on sequence identity are indicated by dye blocks between genomes. Blast hits identity is represented by color intensity shown in the color scale.](MIM-62-150-g001){#mim12570-fig-0001}

Variation of *attL* sequence and distribution of VSP‐II in relation to *attL*‐like sequences {#mim12570-sec-0012}
--------------------------------------------------------------------------------------------

In general, VSP‐II was integrated between two attachment sequences *attL* (14 bp) and *attR* (16 bp). In addition to the typical 14‐bp *attL*, six new categories of *attL*‐like sequences were identified in all 153 *V. cholerae* strains analyzed. An alignment of *attL*‐like sequences showed that the last nine nucleotides of the sequences were identical (Fig. [2](#mim12570-fig-0002){ref-type="fig"}). The 16‐bp *attR* sequence remained identical in all 153 strains carrying any type of VSP‐II.

![**Alignment of seven categories of *attL*‐like sequences** †The typical 14‐bp *attL* sequence of strain N16961 was used as reference. The length of *attL*‐like sequence is indicated in base pairs. Asterisks show identical nucleotides in alignment. Alignment gaps are represented by dashes (--). The seven‐nucleotide extent at both ends of the *attL*‐like sequence (±7 nt) facilitates interpretation of the alignment.](MIM-62-150-g002){#mim12570-fig-0002}

Our data indicated that VSP‐II associated at different frequencies with the type of *attL*‐like sequence. The 14‐bp *attL* was found associated with any type of VSP‐II at the frequency of 139/153 (91%), whereas the remaining six *attL*‐like sequences were found in 9.2% (14/153) of *V. cholerae* strains carrying any type of VSP‐II (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). Of note, six distinct categories of the *attL*‐like sequence were found in 47 wave 1 strains carrying VSP‐II; however, only two categories were found in eight wave 2 strains, and one category in all 96 wave 3 strains (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). Remarkably, 86% (24/28) of *V. cholerae* seventh pandemic strains harboring the 13‐bp *attL*‐like sequence were devoid of VSP‐II (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). The remaining 11 *V. cholerae* strains that did not carry VSP‐II were categorized as non‐seventh pandemic *V. cholerae* strains and did not carry an *attL*‐like motif (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}).

###### 

Distribution of VSP‐II in relation to *attL*‐like sequences among 188 *Vibrio cholerae* strains

           *V. cholerae* seventh pandemic strains (*n *= 175)                                                             
  -------- ---------------------------------------------------- --- --- ---- --- --- --- --- --- ---- --- --- --- --- --- ----
  14 bp‡   36                                                   0   0   0    6   0   0   0   0   96   0   0   0   0   1   0
  15 bp    0                                                    0   0   0    0   0   0   0   0   0    0   0   0   0   1   0
  13 bp    4                                                    0   0   23   0   0   0   1   0   0    0   0   0   0   0   0
  12 bp    1                                                    0   0   0    2   0   0   0   0   0    0   0   0   0   0   0
  11 bp    1                                                    0   0   0    0   0   0   0   0   0    0   0   0   0   0   0
  10 bp    3                                                    0   0   0    0   0   0   0   0   0    0   0   0   0   0   0
  9 bp     2                                                    0   0   0    0   0   0   0   0   0    0   0   0   0   0   0
  Neg§     0                                                    0   0   0    0   0   0   0   0   0    0   0   0   0   0   11
  Total    47                                                   0   0   23   8   0   0   1   0   96   0   0   0   0   2   11

*V. cholerae* O1 pre‐seventh pandemic (*n* = 2), non‐O1/non‐O139 (*n* = 11). ‡14‐bp *attL* in strain N16961 used as reference. §*attL*‐like sequence was absent at the site between VC0489 and VC0517. S, VSP‐II with VC0495--VC0498 deletion; T, typical VSP‐II; V, novel variant identified in this study; −, no genomic island was found at the site between VC0489 and VC0517.
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Novel GI and their distribution {#mim12570-sec-0013}
-------------------------------

Six novel GI were found in the present study. Of these, three GI were integrated at the site between VC0153 and VC0154, and the other three were at the site between VC0208 and VC0209, then designated as GI‐VC0154‐1, −2, and −3; and GI‐VC0209‐1, −2, and −3, respectively (Fig. [3](#mim12570-fig-0003){ref-type="fig"}). GI‐VC0154‐1, −2 and GI‐VC0209‐1, −2 shared two gene clusters known as parts of a core‐conserved genomic backbone region of the typical VSP‐II (Fig. [3](#mim12570-fig-0003){ref-type="fig"}). The six novel GI were carried by 11 *V. cholerae* strains consisting of four of the seventh pandemic wave 1 strains, and seven *V. cholerae* non‐O1/non‐O139 strains (Table [2](#mim12570-tbl-0002){ref-type="table-wrap"}). Of these, four non‐O1/non‐O139 strains were determined to carry either GI‐VC0154‐1 or GI‐VC0154‐3. One out of four strains belonging to wave 1 was found to carry both the typical VSP‐II and GI‐VC0209‐1, and one non‐O1/non‐O139 strain was found to carry both novel VSP‐II and GI‐VC0154‐3 (Table [2](#mim12570-tbl-0002){ref-type="table-wrap"}).

![**Comparative analysis of six novel genomic islands** (a) Genetic organizations of three genomic islands inserted at the site between VC0153 and VC0154 were compared. V1†, V2† and V3† indicate genomic islands GI‐VC0154‐1, −2 and −3, respectively. (b) Genetic organizations of three genomic islands inserted at the site between VC0208 and VC0209 were compared. V1‡, V2‡ and V3‡ indicate genomic islands GI‐VC0209‐1, −2 and −3, respectively. Number of carrier strains is presented (*n*). Putative attachment left and right sites (*attL* and *attR*) are shown by tiny vertical black bars. Genes are shown by arrows, with the direction indicating the strand. Chromosomal flanking genes are in black. Integrase gene is in green. Conserved gene clusters are highlighted in grey. Similar regions based on sequence identity are indicated by dye blocks between genomes. Blast hits identity is represented by color intensity shown in the color scale.](MIM-62-150-g003){#mim12570-fig-0003}

###### 

Distribution of new GI among 188 *Vibrio cholerae* strains

                *V. cholerae* seventh pandemic strains (n = 175)                
  ------------- -------------------------------------------------- --- ---- --- ----
  GI‐VC0154‐1   0                                                  0   0    0   4§
  GI‐VC0154‐2   0                                                  0   0    0   1
  GI‐VC0154‐3   0                                                  0   0    0   1
  GI‐VC0209‐1   4                                                  0   0    0   0
  GI‐VC0209‐2   0                                                  0   0    0   1
  GI‐VC0209‐3   0                                                  0   0    0   4§
  Negative      66                                                 9   96   2   4
  Total         70                                                 9   96   2   11

†O1 pre‐seventh pandemic. ‡non‐O1/non‐O139 group is indicated. §These are the same strains.
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DISCUSSION {#mim12570-sec-0014}
==========

The seventh pandemic strain was estimated to be initiated in 1954 by acquisition of important virulence factors: VSP‐I and −II, El Tor type of CTX phage, and additional mutations before it became the seventh pandemic in 1961 [6](#mim12570-bib-0006){ref-type="ref"}. The typical VSP‐II was found to be dominant in wave 1 and 2 strains, but was not found in all 96 strains of wave 3. It was replaced by a short VSP‐II with VC0495‐VC0498 deletion (Fig. [1](#mim12570-fig-0001){ref-type="fig"}; Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). In wave 3, 95 strains isolated from the Vietnam 2007--2010 outbreaks were identified to be of a highly clonal population (Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). The original strain of these outbreaks, presumably introduced from the Bay of Bengal, was described in previous studies [24](#mim12570-bib-0024){ref-type="ref"}, [25](#mim12570-bib-0025){ref-type="ref"}. After 2010, molecular investigations confirmed that no strain has been reported to carry the short VSP‐II. This is a result of the fact that cholera outbreaks have abated in Vietnam [25](#mim12570-bib-0025){ref-type="ref"}, [26](#mim12570-bib-0026){ref-type="ref"}, [27](#mim12570-bib-0027){ref-type="ref"}. Our data indicated that this short VSP‐II was found dominant in wave 3 strains in Vietnam during the 2007--2010 cholera outbreaks (Fig. [1](#mim12570-fig-0001){ref-type="fig"}; Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). It is important to note that this short VSP‐II was identified in strains isolated from many concurrent outbreaks in 2008--2010 seasons in many Asian countries, Bangladesh, Pakistan, Nepal, and Thailand, and marked a global transmission of the short VSP‐II [5](#mim12570-bib-0005){ref-type="ref"}, [28](#mim12570-bib-0028){ref-type="ref"}, [29](#mim12570-bib-0029){ref-type="ref"}. In wave 3, the typical VSP‐II was displaced by CIRS101 VSP‐II and the short VSP‐II in many endemic areas in Nepal, Pakistan, Bangladesh and Haiti [13](#mim12570-bib-0013){ref-type="ref"}, [28](#mim12570-bib-0028){ref-type="ref"}, [29](#mim12570-bib-0029){ref-type="ref"}, [30](#mim12570-bib-0030){ref-type="ref"}, [31](#mim12570-bib-0031){ref-type="ref"}. Imamura *et al*. examined 79 *V. cholerae* O1 strains of wave 3 and found that after 2010, the typical VSP‐II was completely replaced by CIRS101 VSP‐II in cholera endemic areas of India [12](#mim12570-bib-0012){ref-type="ref"}. Continuous surveillance of these short VSP‐II in endemic and epidemic areas is critical to track its circulation in the global trend of cholera epidemics.

A novel VSP‐II was identified in two non‐O1/non‐O139 *V. cholerae* strains, but was not found in any pandemic *V. cholerae* strain (Fig. [1](#mim12570-fig-0001){ref-type="fig"}; Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}), indicating its limited distribution in local sporadic outbreaks. The finding of the novel VSP‐II indicated a larger genetic variation of VSP‐II in *V. cholerae* non‐O1/non‐O139 strains which are believed to serve as natural reservoirs for GI [9](#mim12570-bib-0009){ref-type="ref"}, [31](#mim12570-bib-0031){ref-type="ref"}, [32](#mim12570-bib-0032){ref-type="ref"}. Of the 35 *V. cholerae* strains lacking VSP‐II, 11 non‐seventh pandemic strains were found to carry a 16‐bp sequence identical to *attR* at the insertion site of VSP‐II; however, a sequence identical to 13‐bp *attL*‐like sequence was found in the remaining 24 seventh pandemic strains at the site (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}).

Typically, VSP‐II was flanked by two attachment sequences, *attL* (14 bp) and *attR* (16 bp) as a consequence of site‐specific integration [11](#mim12570-bib-0011){ref-type="ref"}, [12](#mim12570-bib-0012){ref-type="ref"}. Significantly, seven categories of *attL* sequence, including six newly identified, were found associated at different frequencies with VSP‐II island in this study. VSP‐II linked to the typical 14‐bp *attL* at a high frequency, and to the other categories in a small proportion (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). Interestingly, 86% (24 out of 28 strains) of the 13‐bp *att*L‐like sequence was found in the absence of VSP‐II in 24 *V. cholerae* seventh pandemic strains (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). Murphy and Boyd showed that VSP‐II can be excised from chromosomes and can form a CI and, after excision, the insertion site of VSP‐II contained a sequence identical to the VSP‐II 14‐bp *attL* sequence [11](#mim12570-bib-0011){ref-type="ref"}. However, in our study, the 13‐bp *attL*‐like sequence was found instead of the 14‐bp at the vacant site in all 24 seventh pandemic strains (Table [1](#mim12570-tbl-0001){ref-type="table-wrap"}). Moreover, the strains with or without VSP‐II were found circulated in the seventh pandemic wave 1 and wave 2, indicating no selection disadvantage has been conferred by the loss of VSP‐II among the *V. cholerae* population of clinical isolates (Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). These observations allow us to raise the hypotheses that the 13‐bp *attL*‐like sequence might be involved in promoting excision of VSP‐II from the bacterial genome or in inhibiting re‐integration of CI of VSP‐II. Further, the detection of a 13‐bp *attL*‐like sequence region could be used as a molecular marker for monitoring the absence of VSP‐II among *V. cholerae* seventh pandemic strains.

Two gene clusters, VC0495--VC0498 and VC0504--VC0510, typically found in VSP‐II, were shared by the novel VSP‐II, and also shared by four novel GI (Fig. [3](#mim12570-fig-0003){ref-type="fig"}; Supplementary Table [S2](#mim12570-sup-0002){ref-type="supplementary-material"}). Previous studies reported that the two conserved gene clusters were carried by GI‐81 and GI‐118 [31](#mim12570-bib-0031){ref-type="ref"}, indicating that those conserved gene clusters are commonly shared by many GI.

The integrase encoded in five out of six novel GI, as well as in previously reported GI‐81 and GI‐118, is different from that encoded in any type of VSP‐II. We observed that nine out of 11 *V. cholerae* strains that carried any type of novel GI did not carry any type of VSP‐II, simultaneously (Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). This indicates that novel GI described in the study may have a similar function that possessed by VSP‐II. The entire 96 *V. cholerae* wave 3 strains analyzed in the present study were determined to carry the short VSP‐II with the VC0495--VC0498 deletion (Fig. [1](#mim12570-fig-0001){ref-type="fig"}; Supplementary Table [S1](#mim12570-sup-0001){ref-type="supplementary-material"}). It could be hypothesized that *V. cholerae* strains with the short VSP‐II may have a selection advantage over those with typical VSP‐II, as we observed that strains with the short VSP‐II had been circulated and become predominant in the 2007--2010 cholera endemic seasons and epidemic areas [13](#mim12570-bib-0013){ref-type="ref"}, [28](#mim12570-bib-0028){ref-type="ref"}, [29](#mim12570-bib-0029){ref-type="ref"}, [30](#mim12570-bib-0030){ref-type="ref"}, [31](#mim12570-bib-0031){ref-type="ref"}.

Association of VSP‐II with epidemic potential should not be dismissed concerning the history of the seventh cholera pandemic. The occurrence of different VSP‐II variants coincided with altered CTX prophage, which was observed in cholera outbreaks and had cryptically changed the epidemiology of cholera [4](#mim12570-bib-0004){ref-type="ref"}, [23](#mim12570-bib-0023){ref-type="ref"}, [31](#mim12570-bib-0031){ref-type="ref"}, [33](#mim12570-bib-0033){ref-type="ref"}, [34](#mim12570-bib-0034){ref-type="ref"}. Several distinct shifts in CTX prophages have been shown to be evidence of population changes of *V. cholerae* [23](#mim12570-bib-0023){ref-type="ref"}, [34](#mim12570-bib-0034){ref-type="ref"}. However, the role of VSP‐II in the pathogenesis and dynamic nature of epidemic *V. cholerae* remains largely to be clarified. Variants, such as CIRS101 VSP‐II, a short VSP‐II with VC0495--VC0498 deletion, and WASA VSP‐II were found associated with epidemic tendencies in Haiti, South Asia countries, Western Africa and South America, respectively [4](#mim12570-bib-0004){ref-type="ref"}, [12](#mim12570-bib-0012){ref-type="ref"}, [29](#mim12570-bib-0029){ref-type="ref"}, [31](#mim12570-bib-0031){ref-type="ref"}, [35](#mim12570-bib-0035){ref-type="ref"}.
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